CORRECTION article
Front. Immunol.
Sec. Cancer Immunity and Immunotherapy
Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1660020
Correction: A stage IV lung squamous cell cancer patient with brain metastases, high PD-L1 &TMB, achieves pCR and long-term survival after immune-chemotherapy and radical surgery: a case report and literature review
Provisionally accepted
Xiangyu Xu
Zheng Ma*- Chongqing General Hospital, Chongqing, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Incorrect affiliation In the published article, there was an error in affiliation[1]. Instead of “[Department of Thoracic Surgery, Chongqing People's Hospital, Chongqing, China]”, it should be “[Department of Thoracic Surgery, Chongqing General Hospital, Chongqing University, Chongqing, China]”. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Keywords: Non-small cell lung cancer (NSCLC), brain metastasis, Programmed cell death ligand 1, Tumor mutational burden (TMB), pathological complete response (PCR), circulating tumor DNA (ctDNA)
Received: 05 Jul 2025; Accepted: 10 Jul 2025.
Copyright: © 2025 Xu and Ma. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Zheng Ma, Chongqing General Hospital, Chongqing, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.